Frequently Asked Questions

 

1) Is KinetiCor’s Prospective Motion Correction (PMC) System available for clinical use? 

KinetiCor’s PMC system is strictly for research purposes only and is not cleared or approved for clinical use by any regulatory body. For more information on using PMC for research purposes, please “Contact” us.

 

2) What MRI pulse sequences does KinetiCor’s PMC currently support? 

KinetiCor’s PMC technology can theoretically work on any pulse sequence. For more information on which MRI systems and pulse sequences are currently supported by KinetiCor’s PMC, please “Contact” us.

 

3) Does KinetiCor PMC extend MR scan times? 

Unlike other forms of motion correction technologies, KinetiCor’s real-time PMC technology does not extend the time it takes to conduct an MR scan.

 

4) Does KinetiCor’s PMC system correct for motion of other areas of the body besides the head? 

Currently KinetiCor’s PMC is optimized to correct for head movement and is most often used in brain imaging research. For more information about using PMC to correct for motion other than head motion, please “Contact” us.

 

5) How much does KinetiCor’s PMC system cost? 

Pricing for KinetiCor’s PMC system is dependent on the unique operating and user requirements of each research institution. For more information on pricing, please “Contact” us.

 

6) What types of technical support is provided to Customers using KinetiCor PMC systems? 

KinetiCor offers on-site installation support and post-installation remote technical support to its Customers. The company also offers optional annual technical support contract. For more information on technical support, please “Contact” us.

 

7) Does KinetiCor provide the pulse sequences with its PMC System? 

KinetiCor does not provide pulse sequences to its Customers. Customers are required to obtain pulse sequences through their MR vendor’s mechanisms to distribute experimental non-product MR sequences. Please ask your vendor about sequences with KinetiCor support, or “Contact us

 

Any other suggestions or other questions we should include here are most welcome. Please contact us >

Testimonials

Prospective motion correction systems will have a profound impact on the quality and costs of clinical and research MR imaging. Significant savings will be realized by reducing the need to repeat scans and the need to sedate patients to reduce motion during scanning. This system is an extraordinary integration of real-time control of imaging sequences with a novel method for measuring motion. The system has demonstrated remarkable results that are likely to continue to improve with ongoing development.”

Thomas Prieto, Ph.D., Associate Professor of Neurology, Medical College of Wisconsin

From the very beginning of the project back in 2003 we have believed that the prospective motion correction will revolutionize MRI, especially in non-cooperative subjects and patients. It’s been a long way though, until the tracking technology and the MRI methodology has matured to the present point when we were able to demonstrate its real benefits for the image quality. Interestingly, the prospective motion correction has in a way outperformed our expectations, as it not only effectively suppresses the artifacts for the cases with strong motion, but also improves high-resolution acquisitions when no apparent motion is present.”

Maxim Zaitsev, Ph.D., Department of Radiology, University Medical Centre Freiburg

I consider prospective motion correction technology a major break-through in MRI for clinical and academic applications. In diagnostic imaging it will reduce the number of repeat exams or non-diagnostic results, thus allowing better diagnosis and reducing healthcare costs. In addition, technical advances in MRI lead to ever increasing resolution of MRI images, demanding patients to hold extremely still. The full potential of high resolution imaging will only be unleashed with motion correction technology.”

Oliver Speck, Ph.D., Director, Department of Biomedical Magnetic Resonance, Otto-von-Guericke University

Prospective motion correction will have a huge impact for clinical MRI. It is the patients who need MRI the most who also move the most during the scan – children or the elderly, or patients who have head trauma, dementia, Parkinson’s disease, or brain tumors. With potential cost savings on the order of $1 billion per year, MRI scans may eventually become less expensive and therefore more affordable, which means more people can benefit from an MRI.”

Thomas Ernst, Ph.D., John A. Burns School of Medicine, University of Hawaii